U.S. RESEARCH ROUNDUP-Immunogen, LXP Industrial Trust, TG Therapeutics

ImmunoGen

30/12/2022 13:15

Dec 30 (Reuters) - Wall Street securities analysts revised their ratings and price
targets on several U.S.-listed companies, including Immunogen, LXP Industrial Trust and TG
Therapeutics, on Friday. 
    HIGHLIGHTS
                 * Immunogen Inc  IMGN.O : H.C. Wainwright cuts target price to $15 from $20 
 
                 * LXP Industrial Trust  LXP.N : JP Morgan cuts target price to $11 from $12 
 
                 * TG Therapeutics Inc  TGTX.O : Evercore ISI raises target price to $16 from $11 
 
 Following is a summary of research actions on U.S. companies reported by Reuters on Friday.
Stock entries are in alphabetical order. 
                 * Agile Therapeutics Inc  AGRX.O : H.C. Wainwright cuts target price to $3 from $5 
 
                 * Charah Solutions Inc  CHRA.N : Stifel adjusts PT to $17 from $2 to reflect 1-for-10 reverse
 stock split 
 
                 * Immunogen Inc  IMGN.O : H.C. Wainwright cuts target price to $15 from $20 
 
                 * LXP Industrial Trust  LXP.N : JP Morgan cuts target price to $11 from $12 
 
                 * TG Therapeutics Inc  TGTX.O : Evercore ISI raises target price to $16 from $11 
 
 (Compiled by Bengaluru Newsroom)
 ((Diaries@thomsonreuters.com))